{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:08Z","timestamp":1793608028398,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008549","name":"Shanxi Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["202403021222222"],"award-info":[{"award-number":["202403021222222"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129158","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:49:22Z","timestamp":1789141762000},"page":"129158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Effective protection against PRRSV NADC30 by recombinant chimpanzee adenovirus vaccines expressing GP35 or M-GP5 fusion proteins"],"prefix":"10.1016","volume":"92","author":[{"given":"Chi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waner","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaxi","family":"Duoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruipeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.129158_bb0005","doi-asserted-by":"crossref","unstructured":"Gao F, Wen G. Strategies and scheming: the war between PRRSV and host cells. Virol J 2025;22(1):191. Epub 20250611. doi:https:\/\/doi.org\/10.1186\/s12985-025-02685-y. [PubMed PMID: 40500743; PubMed Central PMCID: PMCPMC12153163].","DOI":"10.1186\/s12985-025-02685-y"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129158_bb0010","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.21873\/invivo.13982","article-title":"Global challenges and advancements in the management of pivotal porcine\/swine viral diseases","volume":"39","author":"Kwon","year":"2025","journal-title":"In Vivo"},{"key":"10.1016\/j.vaccine.2026.129158_bb0015","doi-asserted-by":"crossref","unstructured":"Li C, Xu H, Li J, Gong B, Guo Z, Xiang L, et al. Genetic evolution and alterations in pathogenicity of highly pathogenic porcine reproductive and respiratory syndrome virus. Virulence 2025;16(1):2504124. Epub 20250522. doi:https:\/\/doi.org\/10.1080\/21505594.2025.2504124. [PubMed PMID: 40401680; PubMed Central PMCID: PMCPMC12101601].","DOI":"10.1080\/21505594.2025.2504124"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129158_bb0020","first-page":"11","article-title":"PRRSV, the virus","volume":"31","author":"Meulenberg","year":"2000","journal-title":"Vet Res"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129158_bb0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0042-6822(95)80030-1","article-title":"Characterization of proteins encoded by ORFs 2 to 7 of Lelystad virus","volume":"206","author":"Meulenberg","year":"1995","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129158_bb0030","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s007050050662","article-title":"Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates","volume":"145","author":"Dea","year":"2000","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2026.129158_bb0035","doi-asserted-by":"crossref","unstructured":"Xie CZ, Wang Z, Ha Z, Zhang Y, Xie YB, Zhang H, et al. Genetic characterization of a new NSP2-deletion porcine reproductive and respiratory syndrome virus in China. Microb Pathog 2021;150:104729. Epub 20210109. doi:https:\/\/doi.org\/10.1016\/j.micpath.2021.104729. [PubMed PMID: 33429053].","DOI":"10.1016\/j.micpath.2021.104729"},{"key":"10.1016\/j.vaccine.2026.129158_bb0040","doi-asserted-by":"crossref","unstructured":"He Z, Li F, Liu M, Liao J, Guo C. Porcine reproductive and respiratory syndrome virus: challenges and advances in vaccine development. Vaccines (Basel) 2025;13(3). Epub 20250228. doi:https:\/\/doi.org\/10.3390\/vaccines13030260. PubMed PMID: 40266104; PubMed Central PMCID: PMCPMC11945896.","DOI":"10.3390\/vaccines13030260"},{"key":"10.1016\/j.vaccine.2026.129158_bb0045","doi-asserted-by":"crossref","unstructured":"Kim H, Kim HK, Jung JH, Choi YJ, Kim J, Um CG, et al. The assessment of efficacy of porcine reproductive respiratory syndrome virus inactivated vaccine based on the viral quantity and inactivation methods. Virol J. 2011;8:323. Epub 20110627. doi:https:\/\/doi.org\/10.1186\/1743-422x-8-323. PubMed PMID: 21703032; PubMed Central PMCID: PMCPMC3141684.","DOI":"10.1186\/1743-422X-8-323"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129158_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/088282404322875430","article-title":"Impact of immunizations with porcine reproductive and respiratory syndrome virus on lymphoproliferative recall responses of CD8+ T cells","volume":"17","author":"Bassaganya-Riera","year":"2004","journal-title":"Viral Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129158_bb0055","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/vim.2005.18.381","article-title":"Porcine reproductive and respiratory syndrome (PRRS) virus-specific interferon-gamma(+) T-cell responses after PRRS virus infection or vaccination with an inactivated PRRS vaccine","volume":"18","author":"Piras","year":"2005","journal-title":"Viral Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2026.129158_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.vetmic.2004.05.006","article-title":"The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs","volume":"102","author":"Nilubol","year":"2004","journal-title":"Vet Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129158_bb0065","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00705-002-0943-y","article-title":"Adenoviral-expressed GP5 of porcine respiratory and reproductive syndrome virus differs in its cellular maturation from the authentic viral protein but maintains known biological functions","volume":"148","author":"Gagnon","year":"2003","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2026.129158_bb0070","doi-asserted-by":"crossref","unstructured":"Shen G, Jin N, Ma M, Jin K, Zheng M, Zhuang T, et al. Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5\/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18. Vaccine 2007;25(21):4193\u2013202. Epub 20070322. doi:https:\/\/doi.org\/10.1016\/j.vaccine.2007.03.010. PubMed PMID: 17418456.","DOI":"10.1016\/j.vaccine.2007.03.010"},{"key":"10.1016\/j.vaccine.2026.129158_bb0075","doi-asserted-by":"crossref","unstructured":"Luo Q, Zheng Y, Zhang H, Yang Z, Sha H, Kong W, et al. Research progress on glycoprotein 5 of porcine reproductive and respiratory syndrome virus. Animals (Basel) 2023;13(5). Epub 20230223. doi:https:\/\/doi.org\/10.3390\/ani13050813. PubMed PMID: 36899670; PubMed Central PMCID: PMCPMC10000246.","DOI":"10.3390\/ani13050813"},{"key":"10.1016\/j.vaccine.2026.129158_bb0080","doi-asserted-by":"crossref","unstructured":"Popescu LN, Trible BR, Chen N, Rowland RRR. GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) as a target for homologous and broadly neutralizing antibodies. Vet Microbiol 2017;209:90\u20136. Epub 20170429. doi:https:\/\/doi.org\/10.1016\/j.vetmic.2017.04.016. PubMed PMID: 28528961.","DOI":"10.1016\/j.vetmic.2017.04.016"},{"key":"10.1016\/j.vaccine.2026.129158_bb0085","doi-asserted-by":"crossref","unstructured":"Xiong G, Li Y, Chen F, Xiong X, Wang Q, Zhang L, et al. Evaluation of Zika virus DNA vaccines based on NS1 and domain III of E. Int Immunopharmacol 2022;113(Pt A):109308. Epub 20221021. doi:https:\/\/doi.org\/10.1016\/j.intimp.2022.109308. [PubMed PMID: 36274487].","DOI":"10.1016\/j.intimp.2022.109308"},{"key":"10.1016\/j.vaccine.2026.129158_bb0090","doi-asserted-by":"crossref","unstructured":"Hick PM, Finlaison DS, Parrish K, Gu X, Hayton P, O'Connor T, et al. Experimental infections of pigs with Japanese Encephalitis Virus Genotype 4. Microorganisms 2024;12(11). Epub 20241026. doi:https:\/\/doi.org\/10.3390\/microorganisms12112163. PubMed PMID: 39597552; PubMed Central PMCID: PMCPMC11596907.","DOI":"10.3390\/microorganisms12112163"},{"key":"10.1016\/j.vaccine.2026.129158_bb0095","doi-asserted-by":"crossref","unstructured":"Long J, Liu K, Chen Y, Wang X, Su Z, Li G, et al. Attenuation of a contemporary Chinese PRRSV-1 strain via serial cell passage and evaluation of its protective efficacy as a modified live virus vaccine candidate. Virology 2026;615:110746. Epub 20251129. doi:https:\/\/doi.org\/10.1016\/j.virol.2025.110746. PubMed PMID: 41325727.","DOI":"10.1016\/j.virol.2025.110746"},{"key":"10.1016\/j.vaccine.2026.129158_bb0100","doi-asserted-by":"crossref","unstructured":"Yu Y, Zhang Q, Cao Z, Tang YD, Xia D, Wang G, et al. Recent advances in Porcine Reproductive and Respiratory Syndrome Virus NADC30-Like research in China: molecular characterization, pathogenicity, and control. Front Microbiol. 2021;12:791313. Epub 20220111. doi:https:\/\/doi.org\/10.3389\/fmicb.2021.791313. PubMed PMID: 35087492; PubMed Central PMCID: PMCPMC8787316.","DOI":"10.3389\/fmicb.2021.791313"},{"key":"10.1016\/j.vaccine.2026.129158_bb0105","doi-asserted-by":"crossref","unstructured":"Ye Z, Zhang M, Yuan L, Wang W, Zhu Z, Wen W, et al. Molecular characterization of a recombinant NADC30-like PRRSV strain with a novel gene deletion pattern in Nsp2 gene. Vet Sci 2025;12(10). Epub 20251013. doi:https:\/\/doi.org\/10.3390\/vetsci12100983. PubMed PMID: 41150123; PubMed Central PMCID: PMCPMC12567703.","DOI":"10.3390\/vetsci12100983"},{"key":"10.1016\/j.vaccine.2026.129158_bb0110","doi-asserted-by":"crossref","unstructured":"Meulenberg JJ, Petersen-den Besten A. Identification and characterization of a sixth structural protein of Lelystad virus: the glycoprotein GP2 encoded by ORF2 is incorporated in virus particles. Virology 1996;225(1):44\u201351. doi:https:\/\/doi.org\/10.1006\/viro.1996.0573. [PubMed PMID: 8918532].","DOI":"10.1006\/viro.1996.0573"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129158_bb0115","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/BF01322671","article-title":"Comparison of the structural protein coding sequences of the VR-2332 and Lelystad virus strains of the PRRS virus","volume":"140","author":"Murtaugh","year":"1995","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2026.129158_bb0120","doi-asserted-by":"crossref","unstructured":"Kapur V, Elam MR, Pawlovich TM, Murtaugh MP. Genetic variation in porcine reproductive and respiratory syndrome virus isolates in the Midwestern United States. J Gen Virol 1996;77 ( Pt 6):1271\u20136. doi:https:\/\/doi.org\/10.1099\/0022-1317-77-6-1271. [PubMed PMID: 8683216].","DOI":"10.1099\/0022-1317-77-6-1271"},{"key":"10.1016\/j.vaccine.2026.129158_bb0125","doi-asserted-by":"crossref","unstructured":"Zhou YJ, Yu H, Tian ZJ, Li GX, Hao XF, Yan LP, et al. Genetic diversity of the ORF5 gene of porcine reproductive and respiratory syndrome virus isolates in China from 2006 to 2008. Virus Res. 2009;144(1\u20132):136\u201344. Epub 20090504. doi:https:\/\/doi.org\/10.1016\/j.virusres.2009.04.013. PubMed PMID: 19406176.","DOI":"10.1016\/j.virusres.2009.04.013"},{"key":"10.1016\/j.vaccine.2026.129158_bb0130","doi-asserted-by":"crossref","unstructured":"Salauddin M, Saha S, Hossain MG, Okuda K, Shimada M. Clinical application of Adenovirus (AdV): a comprehensive review. Viruses 2024;16(7). Epub 20240708. doi:https:\/\/doi.org\/10.3390\/v16071094. PubMed PMID: 39066256; PubMed Central PMCID: PMCPMC11281619.","DOI":"10.3390\/v16071094"},{"key":"10.1016\/j.vaccine.2026.129158_bb0135","doi-asserted-by":"crossref","unstructured":"Zhu C, Yang P, Zhou J, Liu X, Huang Y, Wan C. Advances and prospects of fowl adenoviruses vaccine technologies in the past decade. Int J Mol Sci. 2025;26(13). Epub 20250704. doi:https:\/\/doi.org\/10.3390\/ijms26136434. PubMed PMID: 40650210; PubMed Central PMCID: PMCPMC12249492.","DOI":"10.3390\/ijms26136434"},{"key":"10.1016\/j.vaccine.2026.129158_bb0140","doi-asserted-by":"crossref","unstructured":"Sampson AT, Hlav\u00e1\u010d M, Gillman ACT, Douradinha B, Gilbert SC. Developing the next-generation of adenoviral vector vaccines. Hum Vaccin Immunother 2025;21(1):2514356. Epub 20250701. doi:https:\/\/doi.org\/10.1080\/21645515.2025.2514356. [PubMed PMID: 40590260; PubMed Central PMCID: PMCPMC12218739].","DOI":"10.1080\/21645515.2025.2514356"},{"key":"10.1016\/j.vaccine.2026.129158_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-6869-5_1","article-title":"Development of novel vaccines against infectious diseases based on chimpanzee adenoviral vector","volume":"1581","author":"Zhang","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2026.129158_bb0150","doi-asserted-by":"crossref","unstructured":"Alonso-Padilla J, Papp T, Kaj\u00e1n GL, Benk\u0151 M, Havenga M, Lemckert A, et al. Development of novel adenoviral vectors to overcome challenges observed with HAdV-5-based constructs. Mol Ther. 2016;24(1):6\u201316. Epub 20151019. doi:https:\/\/doi.org\/10.1038\/mt.2015.194. PubMed PMID: 26478249; PubMed Central PMCID: PMCPMC4754553.","DOI":"10.1038\/mt.2015.194"},{"key":"10.1016\/j.vaccine.2026.129158_bb0155","doi-asserted-by":"crossref","unstructured":"Peruzzi D, Dharmapuri S, Cirillo A, Bruni BE, Nicosia A, Cortese R, et al. A novel chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines. Vaccine 2009;27(9):1293\u2013300. Epub 20090120. doi:https:\/\/doi.org\/10.1016\/j.vaccine.2008.12.051. PubMed PMID: 19162112; PubMed Central PMCID: PMCPMC7115565.","DOI":"10.1016\/j.vaccine.2008.12.051"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129158_bb0160","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.170.3.1416","article-title":"A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag","volume":"170","author":"Fitzgerald","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2026.129158_bb0165","doi-asserted-by":"crossref","unstructured":"Roy S, Vandenberghe LH, Kryazhimskiy S, Grant R, Calcedo R, Yuan X, et al. Isolation and characterization of adenoviruses persistently shed from the gastrointestinal tract of non-human primates. PLoS Pathog 2009;5(7):e1000503. Epub 20090703. doi:https:\/\/doi.org\/10.1371\/journal.ppat.1000503. [PubMed PMID: 19578438; PubMed Central PMCID: PMCPMC2698151].","DOI":"10.1371\/journal.ppat.1000503"},{"key":"10.1016\/j.vaccine.2026.129158_bb0170","doi-asserted-by":"crossref","unstructured":"Guo J, Mondal M, Zhou D. Development of novel vaccine vectors: chimpanzee adenoviral vectors. Hum Vaccin Immunother. 2018;14(7):1679\u201385. Epub 20180123. doi:https:\/\/doi.org\/10.1080\/21645515.2017.1419108. PubMed PMID: 29300685; PubMed Central PMCID: PMCPMC6067905.","DOI":"10.1080\/21645515.2017.1419108"},{"key":"10.1016\/j.vaccine.2026.129158_bb0175","doi-asserted-by":"crossref","unstructured":"Zhou D, Cun A, Li Y, Xiang Z, Ertl HC. A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus. Mol Ther. 2006;14(5):662\u201372. Epub 20060622. doi:https:\/\/doi.org\/10.1016\/j.ymthe.2006.03.027. PubMed PMID: 16797238.","DOI":"10.1016\/j.ymthe.2006.03.027"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129158_bb0180","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1089\/hum.2006.17.500","article-title":"Efficacy of severe acute respiratory syndrome vaccine based on a nonhuman primate adenovirus in the presence of immunity against human adenovirus","volume":"17","author":"Zhi","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2026.129158_bb0185","doi-asserted-by":"crossref","unstructured":"Hou C, Ni R, Zhao L, Tian M, Long X, Lei C, et al. Recombinant chimpanzee adenovirus expressing spike protein protects chickens against infectious bronchitis virus. Int J Biol Macromol 2024;255:128105. Epub 20231120. doi:https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.128105. [PubMed PMID: 37981286].","DOI":"10.1016\/j.ijbiomac.2023.128105"},{"key":"10.1016\/j.vaccine.2026.129158_bb0190","doi-asserted-by":"crossref","unstructured":"Niu Y, Yan Y, Hu Y, Yang X, Shi H, Zhou P, et al. A novel tetravalent influenza vaccine based on one chimpanzee adenoviral vector. Vaccine 2025;53:126959. Epub 20250301. doi:https:\/\/doi.org\/10.1016\/j.vaccine.2025.126959. [PubMed PMID: 40023902].","DOI":"10.1016\/j.vaccine.2025.126959"},{"key":"10.1016\/j.vaccine.2026.129158_bb0195","doi-asserted-by":"crossref","unstructured":"Van Breedam W, Costers S, Vanhee M, Gagnon CA, Rodr\u00edguez-G\u00f3mez IM, Geldhof M, et al. Porcine reproductive and respiratory syndrome virus (PRRSV)-specific mAbs: supporting diagnostics and providing new insights into the antigenic properties of the virus. Vet Immunol Immunopathol. 2011;141(3\u20134):246\u201357. Epub 20110312. doi:https:\/\/doi.org\/10.1016\/j.vetimm.2011.03.008. PubMed PMID: 21470695.","DOI":"10.1016\/j.vetimm.2011.03.008"},{"key":"10.1016\/j.vaccine.2026.129158_bb0200","doi-asserted-by":"crossref","unstructured":"Li J, Murtaugh MP. Dissociation of porcine reproductive and respiratory syndrome virus neutralization from antibodies specific to major envelope protein surface epitopes. Virology 2012;433(2):367\u201376. Epub 20120912. doi:https:\/\/doi.org\/10.1016\/j.virol.2012.08.026. PubMed PMID: 22981434.","DOI":"10.1016\/j.virol.2012.08.026"},{"key":"10.1016\/j.vaccine.2026.129158_bb0205","doi-asserted-by":"crossref","unstructured":"Li J, Jiang P, Li Y, Wang X, Cao J, Wang X, et al. HSP70 fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus enhanced the immune responses and protective efficacy against virulent PRRSV challenge in pigs. Vaccine 2009;27(6):825\u201332. Epub 20081212. doi:https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.088. PubMed PMID: 19070639.","DOI":"10.1016\/j.vaccine.2008.11.088"},{"key":"10.1016\/j.vaccine.2026.129158_bb0210","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez J, Rasc\u00f3n-Castelo E, Bray J, Lokhandwala S, Mwangi W. Immunogenicity of a recombinant adenovirus expressing porcine reproductive and respiratory syndrome virus polyepitopes. Vet Microbiol. 2017;212:7\u201315. Epub 20171027. doi:https:\/\/doi.org\/10.1016\/j.vetmic.2017.10.020. PubMed PMID: 29173591.","DOI":"10.1016\/j.vetmic.2017.10.020"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:38:08Z","timestamp":1793605088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":42,"alternative-id":["S0264410X26009679"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129158","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective protection against PRRSV NADC30 by recombinant chimpanzee adenovirus vaccines expressing GP35 or M-GP5 fusion proteins","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129158"}}